Weekly Neuroscience Update
Researchers unveiled a fully implantable brain‑computer interface that lets paraplegic patients control a robotic exoskeleton with their thoughts, aiming to restore both walking and its sensation. Parallel advances include an AI pruning framework that mimics infant brain development to slash model size and energy consumption, and a 15‑minute smartphone melatonin test using europium nanoparticles for circadian monitoring. Clinically, a blood assay for phosphorylated tau‑217 can predict amyloid PET changes and early cognitive decline, while high‑salt diets and air pollution are linked to memory deficits and migraines. Together, these breakthroughs accelerate neurotechnology, efficient AI, and preventive neurology.
Weekly Neuroscience Update
A wave of neuroscience research highlights non‑drug therapies and genetic insights that could reshape treatment for mental health, cancer‑related cognitive issues, and metabolic disorders. Transcranial magnetic stimulation shows lasting reduction of PTSD fear responses, while electroacupuncture improves cognition and alleviates...
Weekly Neuroscience Update
A landmark study used deep neural networks and genome‑wide data to map the genetics of regional brain aging, pinpointing areas most vulnerable to Alzheimer’s. Parallel research shows that mentally active sitting reduces dementia risk, while passive TV watching raises it,...
Weekly Neuroscience Update
Recent neuroscience research is reshaping our understanding of brain health by highlighting ethnic diversity in Alzheimer’s biomarkers, a blood‑based test that predicts dementia decades before symptoms, and sex‑specific effects of GLP‑1 weight‑loss drugs. Advanced genomic tools uncovered new autism‑linked variants,...